SCHEMBL28728513

SCHEMBL28728513

CP(C)(=O)c1ccc(Br)cc1C#N

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 3/20 0.36
▸ MAOA P21397 2/20 0.36
▸ CHEK1 O14757 1/20 0.34
▸ AAK1 Q2M2I8 2/20 0.34
▸ SLC1A5 Q15758 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ GAA P10253 1/20 0.32
▸ NOS3 P29474 1/20 0.32
▸ NOS1 P29475 1/20 0.32
▸ NOS2 P35228 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ DRD4 P21917 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29467354 1.00 MAOB (0.36) MAOBMAOACHEK1AAK1SLC1A5
SCHEMBL28728477 0.85 MAOB (0.40) MAOBMAOACHEK1AAK1MCL1
SCHEMBL29450158 0.78 KDM4E (0.49) MCL1GAALMNAALDH1A1
SCHEMBL28722374 0.78 KDM4E (0.49) MCL1GAALMNAALDH1A1
SCHEMBL31690114 0.72 DHODH (0.34) SMN1; SMN2LMNAALDH1A1MAPK1
SCHEMBL29133923 0.72 TSHR (0.46) MCL1SMN1; SMN2GAALMNAALDH1A1
SCHEMBL30509114 0.71 — —
SCHEMBL29062483 0.71 — —
SCHEMBL31690197 0.71 ALDH1A1 (0.38) SMN1; SMN2LMNAALDH1A1MAPK1
SCHEMBL31725110 0.71 KDM4E (0.38) AAK1ALDH1A1HTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114315900-B 3-aryl pyrazolopyrimidine derivative and application thereof 美迪西普胜医药科技(上海)有限公司 2023-09-05 — — CN disclosed
CN-114315900-A 3-arylpyrazolopyrimidine derivative and application thereof 美迪西普胜医药科技(上海)有限公司 2022-04-12 — — CN disclosed
Send feedback